← Alignment Healthcare, Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Revenues:
Earned premiums $754.0m $955.4m $1.2b $1.4b $1.8b $2.7b $3.9b
Other $3.0m $3.8m $688k $2.6m $22.7m $31.6m $37.0m
Depreciation and amortization $14.9m $15.1m $15.8m $17.3m $21.4m $26.9m $30.4m
Income (loss) from operations ($29.5m) ($5.3m) ($178.1m) ($128.6m) ($127.8m) ($101.6m) $14.8m
Other income, net $15.2m $17.7m $17.2m $20.7m $20.4m ($72k) ($89k)
Loss on extinguishment of debt — $0 $0 $2.2m $0 $3.0m $0
Loss before income taxes ($44.7m) ($22.9m) ($195.3m) ($149.3m) ($148.2m) ($128.1m) ($958k)
Total $0 $0 $0 $339k ($22k) $21k $20k
Net loss — ($22.9m) ($195.3m) ($149.6m) ($148.2m) ($128.1m) ($978k)
Less: Net loss attributable to noncontrolling interest — $0 $0 $92k $156k $36k ($254k)
Net loss attributable to Alignment Healthcare, Inc. ($44.7m) ($22.9m) ($195.3m) ($149.5m) ($148.0m) ($128.0m) ($724k)
Net loss per share attributable to Alignment Healthcare, Inc. - basic (in dollars per share) ($0) ($0) ($1) ($1) ($1) ($1) $0
Net loss per share attributable to Alignment Healthcare, Inc. - diluted (in dollars per share) ($0) ($0) ($1) ($1) ($1) ($1) $0
Total weighted-average common shares outstanding - basic (in shares) — (22.9m) 172.0m 181.2m 186.2m 190.8m 198.0m
Total weighted-average common shares outstanding - diluted (in shares) — (22.9m) 172.0m 181.2m 186.2m 190.8m 198.0m
Medical expenses $661.4m $793.0m $1.0b $1.2b $1.6b $2.4b $3.5b
Selling, general, and administrative expenses $110.1m $156.4m $291.0m $295.6m $307.4m $371.4m $443.4m
Interest expense $14.9m $16.9m $17.4m $18.3m $21.2m $23.5m $15.8m
Total expenses $786.4m $964.5m $1.3b $1.6b $2.0b $2.8b $3.9b
Total other expenses — ($22.9m) ($195.3m) $20.7m $20.4m $26.5m $15.7m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.